Reading C, Cole M
Beecham Pharmaceuticals, Research Division, Betchworth, Surrey, England.
J Enzyme Inhib. 1986;1(2):83-104. doi: 10.3109/14756368609020108.
Using a variety of beta-lactamases including those from Escherichia coli (TEM-1), Enterobacter cloacae P99 and Staphylococcus aureus the inhibition profiles (I50 values) were determined for various groups of compounds including penicillins, penicillanic acid derivatives (sulphone and beta-halo substitutions), olivanic acids and clavulanic acid derivatives including substituted ethers and amines. Some of the latter compounds had higher activity than clavulanic acid with and without preincubation of enzyme with inhibitor but they still had poor activity against the P99 enzyme. Improvements in activity against Class I cephalosporinases were obtained with some derivatives of clavulanic acid but this was usually achieved at the expense of activity against clavulanate susceptible beta-lactamases. The olivanic acids had the highest activity against the widest range of beta-lactamases.
使用多种β-内酰胺酶,包括来自大肠杆菌的β-内酰胺酶(TEM-1)、阴沟肠杆菌P99和金黄色葡萄球菌的β-内酰胺酶,测定了各类化合物的抑制谱(I50值),这些化合物包括青霉素、青霉烷酸衍生物(砜和β-卤代取代物)、橄榄酸和棒酸衍生物(包括取代醚和胺)。在有或没有酶与抑制剂预孵育的情况下,一些后者化合物的活性都高于棒酸,但它们对P99酶的活性仍然很差。棒酸的一些衍生物对I类头孢菌素酶的活性有所提高,但这通常是以牺牲对棒酸敏感的β-内酰胺酶的活性为代价的。橄榄酸对范围最广的β-内酰胺酶具有最高活性。